| Obesity |
0 |
1 |
| Biliary Disease |
0 |
0.41 |
| Endoscopy |
0 |
0.36 |
| Gastroenteritis |
0 |
0.36 |
| Eosinophilic Esophagitis |
0 |
0.34 |
| Otolaryngology |
0 |
0.32 |
| Gastroesophageal Reflux Disease |
0 |
0.31 |
| Colorectal Cancer Screening |
0 |
0.3 |
| Colorectal Cancer |
0 |
0.26 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.26 |
| Colon Cancer |
0 |
0.25 |
| Biopsy |
0 |
0.24 |
| Cancer |
0 |
0.24 |
| Esophagitis |
0 |
0.24 |
| Esophagus |
0 |
0.24 |
| Medical Innovations |
0 |
0.24 |
| Stent |
0 |
0.24 |
| Diarrhea |
0 |
0.23 |
| Healthcare and Medical Technology |
0 |
0.23 |
| Biologic Therapy |
0 |
0.18 |
| Fatty Liver |
0 |
0.17 |
| Liver Disease |
0 |
0.17 |
| Metabolic Syndrome |
0 |
0.15 |
| Abdominal Infection |
0 |
0.13 |
| Pancreatitis |
0 |
0.13 |
| Abdominal Bloating |
0 |
0.12 |
| Acute Pancreatitis |
0 |
0.12 |
| Biliary Obstruction |
0 |
0.12 |
| Choledocholithiasis |
0 |
0.12 |
| Clinical Research |
0 |
0.12 |
| Colonoscopy |
0 |
0.12 |
| Dementia |
0 |
0.12 |
| Diet |
0 |
0.12 |
| Duodenum |
0 |
0.12 |
| Dyspepsia |
0 |
0.12 |
| Epidemiology |
0 |
0.12 |
| ERCP |
0 |
0.12 |
| Fellowship |
0 |
0.12 |
| Geriatrics |
0 |
0.12 |
| Immunotherapy |
0 |
0.12 |
| Informed Consent |
0 |
0.12 |
| Intestinal Metaplasia |
0 |
0.12 |
| Liver |
0 |
0.12 |
| Nonalcoholic Steatohepatitis |
0 |
0.12 |
| Nutrition |
0 |
0.12 |
| Prognosis |
0 |
0.12 |
| Proton Pump Inhibitor |
0 |
0.12 |
| Rural Health |
0 |
0.12 |
| Barrett Esophagus |
0 |
0.07 |
| Bowel Preparation |
0 |
0.07 |
| Inflammatory Bowel Disease |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.07 |